Key terms
About MGTX
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MGTX news
Feb 13
8:22am ET
MeiraGTx Earns $50M Milestone from Janssen Pharma Deal
Dec 25
9:30pm ET
Analysts Offer Insights on Healthcare Companies: Vericel (VCEL), Irhythm Technologies (IRTC) and Meiragtx Holdings (MGTX)
Dec 22
6:05am ET
MeiraGTx price target lowered to $18 from $19 at BofA
Dec 22
5:20am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: NeuroPace (NPCE), Meiragtx Holdings (MGTX) and Jazz Pharmaceuticals (JAZZ)
Dec 21
8:33am ET
MeiraGTx files $250M mixed securities shelf
Dec 21
7:05am ET
MeiraGTx announces asset purchase agreement with Janssen for bota-vec
No recent press releases are available for MGTX
MGTX Financials
Key terms
Ad Feedback
MGTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MGTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range